Myung In Pharmaceutical LTD. (KRX:317450)

Market Cap	1.52T
Revenue (ttm)	280.62B
Net Income (ttm)	77.92B
Shares Out	14.60M
EPS (ttm)	6,956.75
PE Ratio	14.98
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	730,794
Average Volume	2,758,405
Open	111,600
Previous Close	109,700
Day's Range	103,800 - 114,600
52-Week Range	97,200 - 134,500
Beta	n/a
RSI	n/a
Earnings Date	n/a

About KRX:317450

Myung In Pharmaceutical LTD., a pharmaceutical company, manufactures ETC and OTC drugs. It offers products in the areas of thrombosis and anti-platelet, anti-hypertensive, anti-angina, anti-parkinson, anti-dementia, anti-epileptics, anti-schizophrenia, anti-depressants, adhd, anti-insomnia, gum disease treatment, gastrointestinal, cold-cough medicine, anti-fever, anti-pain, anti-inflammation agent, nutrition supplements and other pharmaceuticals. The company also provides APIs, such as benztropine mesylate, benidipine hcl, clopidogrel bisulfate...

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 335
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 317450

Financial Performance

In 2024, KRX:317450's revenue was 269.43 billion, an increase of 11.18% compared to the previous year's 242.34 billion. Earnings were 68.67 billion, a decrease of -7.84%.